Skip to main content
    I

    InnovAge Holding Corp (INNV)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $9.58
    +0.11 (+1.16%)

    Market Cap: $1.29B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InnovAge Holding Corp (INNV) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    InnovAge Holding (INNV) trades at 20.4x trailing earnings and 1.3x sales. Its P/S of 1.3x is above its 5-year median of 1.0x. Its forward P/E is 13.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 48.9% higher over the next year. Its free cash flow yield is 5.8%.

    MultipleValue
    P/E (trailing)20.4x
    Forward P/E13.7x
    Price to sales1.3x
    Price to book5.1x
    EV/EBITDA32.7x
    Price to FCF17.1x
    EV/FCF16.3x
    PEGN/A
    FCF yield5.8%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S1.3x1.0xN/A
    P/B5.1x2.7xN/A
    Medians of month-end values through Oct 2026: 59 to 60 months (5-year).

    Valuation History

    Over the 5 year ends shown, its P/S ranged from 0.7x in 2024 to 1.4x in 2022.

    Year endPriceP/EP/SP/B
    2025$5.1928.8x0.8x2.7x
    2024$3.93N/A0.7x2.1x
    2023$6.00N/A1.1x2.9x
    2022$7.18N/A1.4x3.1x
    2021$5.0021.7x1.0x2.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INNV

    What is INNV's forward P/E ratio?

    InnovAge Holding has a forward P/E ratio of 13.7x.

    Is INNV stock overvalued?

    GNG's valuation label for INNV is Fairly valued.

    What is INNV's price to sales ratio?

    InnovAge Holding has a price to sales ratio of 1.3x.